marijuana stocks

GW Pharmaceuticals (GWPH) Looks Good: Stock Up 13.1% – Tale of the Tape

GW Pharmaceuticals plc (GWPH) was a big mover last session with its shares rising over 13% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $79.55 to $84.89.

This biopharmaceutical company has seen 2 positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going ahead to see if Friday’s rally can turn into more strength down the road.

GW Pharmaceuticals currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Investors interested in the Med-Products industry may also consider Abaxis, Inc. (ABAX) which sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Namaste Technologies Inc. (NXTTF) Closes Acquisition of Leading A.I. and Machine-Learning Technology Platform

Namaste Closes Acquisition of Leading A.I. and Machine-Learning Technology Platform Findify.io for…

Innovative Industrial Properties, Inc. (IIPR) Announces Commencement of Registered Exchange Offer for Its 5.50% Senior Notes Due 2026

Innovative Industrial Properties Announces Commencement of Registered Exchange Offer for Its 5.50%…

AbbVie Inc. (ABBV) Submits New Drug Application to U.S. FDA for Investigational ABBV-951

AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa)…

Fire & Flower Holdings Corp. (FFLWF) Announces $30 Million Secured Debt Facility with Circle K Owner

Fire & Flower Announces $30 Million Secured Debt Facility with Circle K…